249 related articles for article (PubMed ID: 31482435)
1. The Role of β-Blockers in Melanoma.
De Giorgi V; Geppetti P; Lupi C; Benemei S
J Neuroimmune Pharmacol; 2020 Mar; 15(1):17-26. PubMed ID: 31482435
[TBL] [Abstract][Full Text] [Related]
2. β-Adrenoceptors as drug targets in melanoma: novel preclinical evidence for a role of β
Dal Monte M; Calvani M; Cammalleri M; Favre C; Filippi L; Bagnoli P
Br J Pharmacol; 2019 Jul; 176(14):2496-2508. PubMed ID: 30471093
[TBL] [Abstract][Full Text] [Related]
3. β-adrenergic-blocking drugs and melanoma: current state of the art.
De Giorgi V; Grazzini M; Gandini S; Benemei S; Asbury CD; Marchionni N; Geppetti P
Expert Rev Anticancer Ther; 2012 Nov; 12(11):1461-7. PubMed ID: 23249110
[TBL] [Abstract][Full Text] [Related]
4. Beta-blockers exert potent anti-tumor effects in cutaneous and uveal melanoma.
Bustamante P; Miyamoto D; Goyeneche A; de Alba Graue PG; Jin E; Tsering T; Dias AB; Burnier MN; Burnier JV
Cancer Med; 2019 Dec; 8(17):7265-7277. PubMed ID: 31588689
[TBL] [Abstract][Full Text] [Related]
5. Can propranolol prevent progression of melanoma?
Kao J; Luu B
JAAPA; 2019 Jun; 32(6):1-5. PubMed ID: 31136408
[TBL] [Abstract][Full Text] [Related]
6. The Potential Efficacy of β-Blockers on Melanoma Survival: A Narrative Review.
Goldust M; Apalla Z; Szepietowski JC; Gupta M; Lotti T
J Drugs Dermatol; 2021 Apr; 20(4):380-383. PubMed ID: 33852249
[TBL] [Abstract][Full Text] [Related]
7. [β-blockers: a new and emerging treatment for melanoma].
De Giorgi V; Gandini S; Grazzini M; Benemei S; Marchionni N; Geppetti P
Recenti Prog Med; 2012 Jan; 103(1):11-6. PubMed ID: 22322621
[TBL] [Abstract][Full Text] [Related]
8. Treatment with β-blockers and reduced disease progression in patients with thick melanoma.
De Giorgi V; Grazzini M; Gandini S; Benemei S; Lotti T; Marchionni N; Geppetti P
Arch Intern Med; 2011 Apr; 171(8):779-81. PubMed ID: 21518948
[TBL] [Abstract][Full Text] [Related]
9. The association between beta-blockers and melanoma survival: evidence of absence or absence of evidence?
Hollestein LM; Nijsten T
Br J Dermatol; 2014 Apr; 170(4):764-5. PubMed ID: 24734945
[No Abstract] [Full Text] [Related]
10. β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study.
Lemeshow S; Sørensen HT; Phillips G; Yang EV; Antonsen S; Riis AH; Lesinski GB; Jackson R; Glaser R
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2273-9. PubMed ID: 21933972
[TBL] [Abstract][Full Text] [Related]
11. Propranolol for Off-label Treatment of Patients With Melanoma: Results From a Cohort Study.
De Giorgi V; Grazzini M; Benemei S; Marchionni N; Botteri E; Pennacchioli E; Geppetti P; Gandini S
JAMA Oncol; 2018 Feb; 4(2):e172908. PubMed ID: 28973254
[TBL] [Abstract][Full Text] [Related]
12. Direct labelling of myocardial beta 1-adrenoceptors. Comparison of binding affinity of 3H-(-)-bisoprolol with its blocking potency.
Kaumann AJ; Lemoine H
Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):27-39. PubMed ID: 2866449
[TBL] [Abstract][Full Text] [Related]
13. The affinity of (-)-propranolol for beta 1- and beta 2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline.
Gille E; Lemoine H; Ehle B; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):60-70. PubMed ID: 2999616
[TBL] [Abstract][Full Text] [Related]
14. β-Blocker use and all-cause mortality of melanoma patients: results from a population-based Dutch cohort study.
Livingstone E; Hollestein LM; van Herk-Sukel MP; van de Poll-Franse L; Nijsten T; Schadendorf D; de Vries E
Eur J Cancer; 2013 Dec; 49(18):3863-71. PubMed ID: 23942335
[TBL] [Abstract][Full Text] [Related]
15. Propranolol induced G0/G1/S phase arrest and apoptosis in melanoma cells via AKT/MAPK pathway.
Zhou C; Chen X; Zeng W; Peng C; Huang G; Li X; Ouyang Z; Luo Y; Xu X; Xu B; Wang W; He R; Zhang X; Zhang L; Liu J; Knepper TC; He Y; McLeod HL
Oncotarget; 2016 Oct; 7(42):68314-68327. PubMed ID: 27582542
[TBL] [Abstract][Full Text] [Related]
16. β
Calvani M; Bruno G; Dal Monte M; Nassini R; Fontani F; Casini A; Cavallini L; Becatti M; Bianchini F; De Logu F; Forni G; la Marca G; Calorini L; Bagnoli P; Chiarugi P; Pupi A; Azzari C; Geppetti P; Favre C; Filippi L
Br J Pharmacol; 2019 Jul; 176(14):2509-2524. PubMed ID: 30874296
[TBL] [Abstract][Full Text] [Related]
17. [Melanoma and non-melanoma skin cancers].
Saito T
Gan To Kagaku Ryoho; 2008 Apr; 35(4):583. PubMed ID: 18467999
[No Abstract] [Full Text] [Related]
18. The role of stress and beta-adrenergic system in melanoma: current knowledge and possible therapeutic options.
Colucci R; Moretti S
J Cancer Res Clin Oncol; 2016 May; 142(5):1021-9. PubMed ID: 26597413
[TBL] [Abstract][Full Text] [Related]
19. Beta-blockers: Historical Perspective and Mechanisms of Action.
Oliver E; Mayor F; D'Ocon P
Rev Esp Cardiol (Engl Ed); 2019 Oct; 72(10):853-862. PubMed ID: 31178382
[TBL] [Abstract][Full Text] [Related]
20. [Beta-adrenergic receptors in the cardiovascular system. The participation of propranolol insensitive beta-adrenoceptors in the regulation of the cardiovascular system].
Malinowska B; Kozłowska H; Zakrzeska A; Kwolek G
Kardiol Pol; 2005 Oct; 63(4 Suppl 2):S399-408. PubMed ID: 20527395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
